Table 2.
Gynecological characteristics of participants.
| czp | ltc | P-value | |
|---|---|---|---|
| MENARCHE, MEAN (SD) | 11.5 (1.1) | 11.9 (1.4) | 0.094 |
| PERIOD DAYS, MEAN (SD) | 4.4 (0.9) | 4.8 (0.9) | 0.070 |
| MENSTRUAL CYCLE LENGTH, MEAN (SD) | 26.6 (2.2) | 27.5 (3.4) | 0.552 |
| DYSMENORRHEA, N (%) | 33 (71.7) | 33 (80.5) | 0.341 |
| OLIGO-MENORRHEA, N (%) | 5 (10.9) | 10 (24.4) | 0.536 |
| MENORRHAGIA, N (%) | 2 (4.3) | 2 (4.9) | 0.980 |
| HIRSUTISM, N (%) | 1 (2.2) | 8 (19.5) | 0.011* |
| INTER-MENSTRUAL BLEEDING, N (%) | 1 (2.2) | 7 (17.1) | 0.024* |
| DYSPAREUNIA, N (%) | 1 (2.2) | 13 (31.7) | <0.001* |
| ASEX SCORE, MEDIAN (IQR) | 16 (14–20) | 7 (6–14) | <0.001* |
| SEXUAL DYSFUNCTION, N (%) | 19 (41.3) | 3 (7.3) | <0.001* |
CZP – Carbamazepine, LTC – Levetiracetam, SD – Standard Deviation, N – Number, ASEX – Arizona Sexual Experience Scale, IQR – Inter-Quartile Range, *Statistically significance.